First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Neoplasms
Interventions: DRUG: GSK4381562|DRUG: Dostarlimab|DRUG: GSK4428859A
Sponsor: GlaxoSmithKline